Skip to NavigationSkip to content

Bayer to cut 12,000 jobs by 2025

Published on 06/12/18 at 10:47am

German pharma giant Bayer is set to cut 12,000 jobs by 2025 as part of a plan to focus on its core life sciences business.

The layoffs, which will affect 10% of Bayer’s 118,000 strong workforce, will be focused on corporate functions in Germany with 6,000 corporate functions jobs to be cut. However 4,100 crop sciences roles will be taken down following the $63 billion deal with Monsanto in which Bayer took on the role of the world’s largest agrochemicals company.

An additional 900 jobs will be cut in R&D and 350 workers will be culled from the newly founded factor VIII manufacturing facility in Wuppertal, Germany.

The announcement sparked protests in Wuppertal as 1,000 Bayer employees protested at the company’s site in the western German city of 350,000.

Jobs in animal health, sun care and foot care will also be affected as Bayer exits the areas.

The cuts come as shares in Bayer have plummeted following the company’s acquisition of Monsanto.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches